Trial
NCT03063242
Sargramostim for Myeloid Dendritic Cell Deficiency
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
—
Condition
Kidney Diseases
Intervention
Sargramostim
Why stopped
Insufficient resources necessary for completion.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-31